Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antimo Gioiello

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Cell Metabolism|September 3, 2009
TGR5-mediated bile acid sensing controls glucose homeostasisCharles Thomas, Antimo Gioiello, Lilia Noriega, et al.
Chemmedchem|February 4, 2026
Structure-Based Discovery of Obeticholic Acid Derivatives as Novel Farnesoid X Receptor Partial Agonists with Improved Selectivity and Reduced Off-Target EffectsDaniela Passeri, Bruno Cerra, Andrea Carotti, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Probing the Binding Site of Bile Acids in TGR5Antonio Macchiarulo, Antimo Gioiello, Charles Thomas, et al.
Biochemical Pharmacology|October 15, 2015
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysisCarmine Giorgio, Simonetta Russo, Matteo Incerti, et al.
Cell Metabolism|December 14, 2011
TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loadingThijs W H Pols, Mitsunori Nomura, Taoufiq Harach, et al.
Journal of Medicinal Chemistry|September 23, 2016
Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic DisordersRoberto Pellicciari, Daniela Passeri, Francesca De Franco, et al.
Journal of Medicinal Chemistry|April 27, 2017
Lead Discovery of Dual G-Quadruplex Stabilizers and Poly(ADP-ribose) Polymerases (PARPs) Inhibitors: A New Avenue in Anticancer TreatmentErica Salvati, Lorenzo Botta, Jussara Amato, et al.
Scientific Reports|September 16, 2015
The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expressionIngrid T G W Bijsmans, Chiara Guercini, José M Ramos Pittol, et al.
Molecules (Basel, Switzerland)|October 25, 2013
Synthesis and structure-activity relationships of amino acid conjugates of cholanic acid as antagonists of the EphA2 receptorSimonetta Russo, Matteo Incerti, Massimiliano Tognolini, et al.
ACS Sensors|February 27, 2023
Ratiometric Two-Photon Near-Infrared Probe to Detect DPP IV in Human Plasma, Living Cells, Human Tissues, and Whole Organisms Using ZebrafishJavier Valverde-Pozo, Jose M Paredes, Thomas J Widmann, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Cell Metabolism|September 3, 2009
TGR5-mediated bile acid sensing controls glucose homeostasisCharles Thomas, Antimo Gioiello, Lilia Noriega, et al.
Chemmedchem|February 4, 2026
Structure-Based Discovery of Obeticholic Acid Derivatives as Novel Farnesoid X Receptor Partial Agonists with Improved Selectivity and Reduced Off-Target EffectsDaniela Passeri, Bruno Cerra, Andrea Carotti, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Probing the Binding Site of Bile Acids in TGR5Antonio Macchiarulo, Antimo Gioiello, Charles Thomas, et al.
Biochemical Pharmacology|October 15, 2015
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysisCarmine Giorgio, Simonetta Russo, Matteo Incerti, et al.
Cell Metabolism|December 14, 2011
TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loadingThijs W H Pols, Mitsunori Nomura, Taoufiq Harach, et al.
Journal of Medicinal Chemistry|September 23, 2016
Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic DisordersRoberto Pellicciari, Daniela Passeri, Francesca De Franco, et al.
Journal of Medicinal Chemistry|April 27, 2017
Lead Discovery of Dual G-Quadruplex Stabilizers and Poly(ADP-ribose) Polymerases (PARPs) Inhibitors: A New Avenue in Anticancer TreatmentErica Salvati, Lorenzo Botta, Jussara Amato, et al.
Scientific Reports|September 16, 2015
The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expressionIngrid T G W Bijsmans, Chiara Guercini, José M Ramos Pittol, et al.
Molecules (Basel, Switzerland)|October 25, 2013
Synthesis and structure-activity relationships of amino acid conjugates of cholanic acid as antagonists of the EphA2 receptorSimonetta Russo, Matteo Incerti, Massimiliano Tognolini, et al.
ACS Sensors|February 27, 2023
Ratiometric Two-Photon Near-Infrared Probe to Detect DPP IV in Human Plasma, Living Cells, Human Tissues, and Whole Organisms Using ZebrafishJavier Valverde-Pozo, Jose M Paredes, Thomas J Widmann, et al.
Pageof 9